CORRECTION: Agereh Expands Intelligent Transportation Portfolio with Launch of Smart Door Sensor™ and retains Hillside C&M Inc.
Tai Software and OpenTrack Announce Integration Bringing AI-Native End-to-End Container Visibility Directly into Tai TMS
Joveo’s 2026 Recruiting Benchmarks Report Reveals Up to 9x Growth in Applicant Volume Over the Past Three Years
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.
SATO Technologies Corp. Provides Strategic Review and Operational Update
PRESS RELEASE Immunocore receives positive CHMP opinion for KIMMTRAK® (tebentafusp) for the treatment of unresectable…
Toronto, Ontario–(Newsfile Corp. – February 25, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…
Saint Herblain (France), February 25, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the…
MALVERN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax…
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Please replace the release dated February 24th, 2022, with the following…
WARREN, N.J., Feb. 24, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
Aiming to strengthen uninterruptible-power-supply business in North America TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced…
Company working to accelerate lead clinical programs; expects multiple clinical readouts in 2022 WESTPORT, Conn.,…
Recent independent Data Safety Monitoring Board (DSMB) review recommended the INTEGRIS-IPF Phase 2a trial continue…
Mesoblast Prepares for Resubmission of Biologics License Application Late-Stage Clinical Pipeline Late-Stage Clinical Pipeline NEW…
JSP191 is well tolerated with no treatment-related severe adverse events in 17 subjects with myelodysplastic…
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
MALVERN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax…
Montrouge, France, February 24, 2022 DBV Technologies to Report Full Year 2021 Financial Results and…
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
SAN CARLOS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
Well-capitalized with $375.1 million at the end of 2021, funding planned operations into 2024 CAMBRIDGE,…
Company begins 2022 with multiple active programs with data readouts expected this year Initial data…
Phase 1/2 trial of CDK9 inhibitor KB-0742 continues to enroll patients in the dose escalation…